Clinical Trial

CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, open-label, first-in-human, fixed-dose study in patients with pancreatic cancer.
Trial Details
NCT Number NCT07425483
Lead Sponsor Changhai Hospital
Collaborators: National Key Laboratory of Immunity and Inflammation
Conditions Pancreatic Cancer
Enrollment 9 participants
Start Date 2026-02-12
Primary Completion 2026-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-23